Drugs Made In America Acquisition II Corp.

DMII

Exchange: Nasdaq
Industry: Blank Checks
SEC CIK: 0002040475

SEC filings (opens in a new tab)

No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $457.4M in total; no superinvestor holds it.

Other share classesDMIIR DMIIU

Q4 2025 vs. Q3 2025

How the institutions holding Drugs Made In America Acquisition II Corp. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of DMII: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Q4 2025	Change
Holders	0	51	+51
Shares	0	34.7M	+34.7M
Value	$0	$342.9M	+$342.9M

New holders (51)

Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to DMII in Q4 2025
Institution	Shares	Value	% of portfolio
Magnetar Financial LLC	2,700,000	$26.7M	0.26%
Glazer Capital, LLC	2,349,899	$23.3M	0.61%
Vivaldi Asset Management, LLC	2,068,118	$20.5M	1.24%
Hudson Bay Capital Management LP	1,969,030	$19.5M	0.11%
Millennium Management LLC	1,500,000	$14.8M	0.01%
Polar Asset Management Partners Inc.	1,500,000	$14.8M	0.29%
Tenor Capital Management Co., L.P.	1,500,000	$14.8M	0.21%
HGC Investment Management Inc.	1,230,980	$12.2M	2.58%
CNH Partners LLC	1,151,400	$11.4M	0.24%
Karpus Management, Inc.	1,143,625	$11.3M	0.35%
Aristeia Capital LLC	1,100,000	$10.9M	0.31%
Wolverine Asset Management LLC	1,062,773	$10.5M	0.15%
D. E. Shaw & Co., Inc.	1,000,000	$9.90M	0.01%
Omers Administration Corp	1,000,000	$9.90M	0.07%
Davidson Kempner Capital Management LP	1,000,000	$9.90M	0.15%
Two Sigma Investments, LP	886,544	$8.78M	0.01%
Picton Mahoney Asset Management	875,000	$8.66M	0.09%
CSS LLC	806,001	$7.98M	0.45%
HighTower Advisors, LLC	789,614	$7.82M	0.01%
Context Capital Management, LLC	750,000	$7.42M	0.19%
Moore Capital Management, LP	750,000	$7.42M	0.15%
Ghisallo Capital Management LLC	750,000	$7.42M	0.33%
Radcliffe Capital Management, L.P.	575,607	$5.70M	0.31%
Westchester Capital Management, LLC	500,000	$4.95M	0.23%
HBK Investments L P	500,000	$4.95M	0.05%
Sculptor Capital LP	500,000	$4.95M	0.06%
Whitebox Advisors LLC	450,000	$4.46M	0.07%
Shaolin Capital Management LLC	425,000	$4.21M	0.16%
Wealthspring Capital LLC	408,950	$4.05M	0.96%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys	400,000	$3.96M	0.02%
BNP Paribas Arbitrage, SA	348,600	$3.45M	0.00%
Lineage Point Capital LP	336,360	$3.33M	1.26%
Sona Asset Management (US) LLC	300,000	$2.97M	0.10%
Periscope Capital Inc.	265,500	$2.63M	0.51%
Mint Tower Capital Management B.V.	250,000	$2.48M	0.31%
Verition Fund Management LLC	200,000	$1.98M	0.01%
Toronto Dominion Bank	189,909	$1.88M	0.00%
Clear Street Group Inc.	181,521	$1.80M	0.01%
JPMorgan Chase & Co	129,630	$1.28M	0.00%
Mizuho Securities USA LLC	216,307	$1.26M	0.02%
DLD Asset Management, LP	112,200	$1.11M	0.12%
PEAK6 LLC	100,000	$990.0K	0.03%
Cable Car Capital LLC	100,000	$990.0K	0.06%
Quarry LP	100,000	$990.0K	0.16%
Royal Bank of Canada	66,200	$655.0K	0.00%
Deltec Asset Management LLC	50,000	$495.0K	0.08%
Abc Arbitrage SA	40,000	$396.0K	0.04%
Dakota Wealth Management	36,825	$364.6K	0.01%
Virtu Financial LLC	31,991	$317.0K	0.01%
Geode Capital Management, LLC	26,801	$265.3K	0.00%
Morgan Stanley	169	$1.67K	0.00%

Sold out (0)

Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q3 2025 and filed for Q4 2025 without it.

None.